Home Visit
Upload
C-erb-B2 (Her2/Neu) for Gastric Carcinoma IHC
No special precautions
Recommended for
Male, Female
Report
Within 1 Week
Blood test at Home
NABL & CAP Accredited Labs
Accurate & Quality Test Reports
Trusted by Leading Doctors & Hospitals
Overview
Gastric carcinoma, also known as stomach cancer, is the abnormal growth of cells in the stomach lining. It can be a serious and aggressive form of cancer. Common symptoms include abdominal pain, indigestion, weight loss, and nausea. Early detection is crucial for effective treatment. The C-erb-B2 (Her2 Neu) test for gastric carcinoma is used to assess the expression levels of the human epidermal growth factor receptor 2 (HER2) protein in gastric (stomach) cancer tissue. Similar to its application in breast cancer, this test helps determine the presence of HER2 overexpression, guiding treatment decisions for gastric carcinoma.
C-erb-B2 (Her2/Neu) for Gastric Carcinoma IHC Price
Metropolis Healthcare is a leading diagnostics centre and pathology lab in India equipped with the latest state-of-the-art technologies that provides the C-erb-B2 (Her2/Neu) for Gastric Carcinoma IHC with a clear pricing structure.
The C-erb-B2 (Her2/Neu) for Gastric Carcinoma IHC Price in Mumbai is ₹ 2,330 .
We are committed to deliver accurate and quality results from the best labs in India with complete transparency regarding test cost and turnaround time. No matter where you are, we strive to offer patients high-quality service that is affordable and accessible.
Frequently Asked Questions
The C-erb-B2 (Her2 Neu) test detects the HER2 protein in gastric cancer cells. Overexpression of HER2 in gastric carcinoma is associated with more aggressive tumor behavior, and it can influence treatment choices.
- The primary purpose of the C-erb-B2 (Her2 Neu) test is to identify patients with gastric carcinoma whose tumors exhibit HER2 overexpression.
- To determine the aggressiveness of gastric carcinoma.
- To guide targeted treatment options, such as HER2-targeted therapies. It helps in determining the most appropriate therapeutic approach, especially for the use of drugs targeting HER2, such as trastuzumab (Herceptin).
- To assess the response to treatment and disease progression.
This test may be recommended if you have been diagnosed with gastric carcinoma or if there is suspicion of gastric cancer based on symptoms or other diagnostic tests.
If the C-erb-B2 (Her2 Neu) test results indicate abnormal levels of HER2 expression in gastric carcinoma, it suggests that the patient's tumor is HER2-positive. In such cases, targeted therapies like trastuzumab (Herceptin) may be considered as part of the treatment strategy. It's important to discuss your test results with your doctor, who will interpret them in the context of your medical history and other diagnostic tests.
- A small sample of gastric carcinoma tissue will be taken from a previous biopsy or surgery.
- The sample will be analysed for the presence and quantity of C-erb-B2 (Her2 Neu) protein using immunohistochemical staining.
- The analysis will help determine the level of Her2 Neu protein expression in the gastric carcinoma cells.
Before the test:
- Make sure to provide the original histopathology report and any relevant clinical and radiological details
- You may need to stop certain medications or follow specific instructions provided by your doctor.
- Other immunohistochemistry (IHC) markers to assess additional proteins or receptors involved in gastric carcinoma
- Molecular testing to identify specific genetic mutations or alterations that may guide treatment decisions
- Imaging tests such as CT scans or endoscopies to determine the extent of gastric carcinoma
- Her2 Neu testing for gastric carcinoma
- Her2 Neu immunohistochemistry for gastric cancer
Ratings & Reviews (0)
Why Metropolis?
Metropolis has a team of 200 senior pathologists and over 2000 technicians delivering diagnostic solutions in the areas of routine, semi specialty and super specialty domains like Oncology, Neurology, Gynaecology, Nephrology and many more.
We offer a comprehensive range of 4000+ clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.
WhatsApp